StromaGenesi

Financials Projections

Substantial revenue and profit generation in 3-5 years

$, 000

Y1

Y2

Y3

Y4

Y5

Y6

Y7

Y8

Y9

Y10

ProstaGene Revenue

$-

$-

$19,139

$38,279

$83,851

$167,701

$348,162

$377,334

$440,541

$440,541

CCR5 Revenue

$-

$-

$-

$10,585

$51,750

$151,211

$395,666

$604,322

$766,485

$878,271

Cav-1 Revenue

$-

$-

$1,902

$6,705

$15,825

$33,090

$67,805

$105,100

$132,480

$145,850

Total Revenue

$-

$-

$21,059

$55,569

$151,426

$352,002

$811,633

$1,086,756

$1,339,505

$1,464,661

YoY growth (%)

$-

164%

173%

132%

131%

34%

23%

9%

Gross Margin

$-

$-

$18,857

$49,898

$135,846

$316,591

$731,125

$975,727

$1,192,651

$1,301,456

% of sales

$-

90%

90%

90%

90%

90%

90%

89%

89%

Operating Profit

-$ 6,000

-$9,000

$5,457

$33,398

$113,398

$289,491

$701,920

$944,212

$1,158,600

$1,264,621

% of sales

26%

60%

75%

82%

86%

87%

86%

86%

Free Cash Flow

-$ 6,000

-$9,000

$3,216

$23,611

$81,390

$208,761

$507,288

$696,695

$858,419

$942,251

Drop in your details to view our Financial Projections